пятница, 20 мая 2016 г.

ZIOPHARM Oncology Inc. (ZIOP) Receives "Sell" Rating from Wells Fargo

ZIOPHARM Oncology Inc. (ZIOP) Receives "Sell" Rating from Wells Fargo


ZIOPHARM Oncology opened at 6.87 on Thursday. The company's 50 day moving average is $7.82 and its 200-day moving average is $8.40.



from Biotech News